StockData

China Pharma Holdings, Inc. (CPHI) stock

CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.56+0.02 (+3.09%)

Close on Nov 12, 2026Market cap $24.09MP/E –Yield –

China Pharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

China Pharma's price to book ratio was 0.6× on Nov 11, 2026, against 0.6× a year earlier. Over the last 5 years it ranged from 0.1× to 34.5×, with a median of 5.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.6×+0.1
2025Dec 31, 20250.5×−5.9
2024Dec 31, 20246.4×+0.7
2023Dec 29, 20235.6×−12.2
2022Dec 30, 202217.8×−15.5
2021Dec 31, 202133.3×+8.4
2020Dec 31, 202025.0×+21.2
2019Dec 31, 20193.8×+0.8
2018Dec 31, 20183.0×+1.6
2017Dec 29, 20171.3×−0.4
2016Dec 30, 20161.7×+0.9
2015Dec 31, 20150.9×−0.3
2014Dec 31, 20141.1×+0.1
2013Dec 31, 20131.1×+0.5
2012Dec 31, 20120.6×−1.5
2011Dec 30, 20112.1×−12.5
2010Dec 31, 201014.6×–

More China Pharma figures

See a number that looks wrong?